PDB4pfk; Evans PR, Farrants GW, Hudson PJ (June 1981). “Phosphofructokinase: structure and control”. 《Philosophical Transactions of the Royal Society B》 293 (1063): 53–62. doi:10.1098/rstb.1981.0059. PMID6115424. 2011년 6월 8일에 원본|보존url=은 |url=을 필요로 함 (도움말)에서 보존된 문서.|확인날짜=는 |url=을 필요로 함 (도움말)
Shirakihara Y, Evans PR (December 1988). “Crystal structure of the complex of phosphofructokinase from Escherichia coli with its reaction products”. 《J. Mol. Biol.》 204 (4): 973–94. doi:10.1016/0022-2836(88)90056-3. PMID2975709.
Banaszak K, Mechin I, Obmolova G, Oldham M, Chang SH, Ruiz T, Radermacher M, Kopperschläger G, Rypniewski W (March 2011). “The crystal structures of eukaryotic phosphofructokinases from baker's yeast and rabbit skeletal muscle”. 《J Mol Biol》 407 (7): 284–97. doi:10.1016/j.jmb.2011.01.019. PMID21241708.
Peskov K, Goryanin I, Demin O (August 2008). “Kinetic model of phosphofructokinase-1 from Escherichia coli”. 《J Bioinform Comput Biol》 6 (4): 843–67. doi:10.1142/S0219720008003643. PMID18763746.
Hellinga HW, Evans PR (1987). “Mutations in the active site of Escherichia coli phosphofructokinase”. 《Nature》 327 (6121): 437–9. doi:10.1038/327437a0. PMID2953977.
Papagianni M, Avramidis N (May 2012). “Engineering the central pathways in Lactococcus lactis: functional expression of the phosphofructokinase (pfk) and alternative oxidase (aox1) genes from Aspergillus niger in Lactococcus lactis facilitates improved carbon conversion rates under oxidizing conditions”. 《Enzyme and Microbial Technology》 51 (113): 125–30. doi:10.1016/j.enzmictec.2012.04.007. PMID22759530.
Coelho WS, Sola-Penna M (Jan 2013). “Serotonin regulates 6-phosphofructo-1-kinase activity in a PLC-PKC-CaMK II- and Janus kinase-dependent signaling pathway”. 《Mol. Cell. Biochem.》 372 (1–2): 211–20. doi:10.1007/s11010-012-1462-0. PMID23010892.
Nakajima H, Raben N, Hamaguchi T, Yamasaki T (March 2002). “Phosphofructokinase deficiency; past, present and future”. 《Curr. Mol. Med.》 2 (2): 197–212. doi:10.2174/1566524024605734. PMID11949936.
Bruser A, KirchbergerJ, Schoneberg T (Oct 2012). “Altered allosteric regulation of muscle 6-phosphofructokinase causes Tarui disease”. 《Biochem Biophys Res Commun》 427 (1): 133–7. doi:10.1016/j.bbrc.2012.09.024. PMID22995305.
Brüser A, Kirchberger J, Schöneberg T (October 2012). “Altered allosteric regulation of muscle 6-phosphofructokinase causes Tarui disease”. 《Biochem. Biophys. Res. Commun.》 427 (1): 133–7. doi:10.1016/j.bbrc.2012.09.024. PMID22995305.
Gomez LS, Zancan P, Marcondes MC, Ramos-Santos L, Meyer-Fernandes JR, Sola-Penna M, Da Silva D (Feb 2013). “Resveratrol decreases breast cancer cell viability and glucose metabolism by inhibiting 6-phosphofructo-1-kinase”. 《Biochimie》 95 (6): 1336–43. doi:10.1016/j.biochi.2013.02.013. PMID23454376.
Vaz CV, Alves MG, Marques R, Moreira PI, Oliveira PF, Maia CJ, Socorro S (Feb 2013). “Androgen-responsive and nonresponsive prostate cancer cells present a distinct glycolytic metabolism profile”. 《Int J Biochem Cell Biol》 44 (11): 2077–84. doi:10.1016/j.biocel.2012.08.013. PMID22964025.
PDB4pfk; Evans PR, Farrants GW, Hudson PJ (June 1981). “Phosphofructokinase: structure and control”. 《Philosophical Transactions of the Royal Society B》 293 (1063): 53–62. doi:10.1098/rstb.1981.0059. PMID6115424. 2011년 6월 8일에 원본|보존url=은 |url=을 필요로 함 (도움말)에서 보존된 문서.|확인날짜=는 |url=을 필요로 함 (도움말)
PDB4pfk; Evans PR, Farrants GW, Hudson PJ (June 1981). “Phosphofructokinase: structure and control”. 《Philosophical Transactions of the Royal Society B》 293 (1063): 53–62. doi:10.1098/rstb.1981.0059. PMID6115424. 2011년 6월 8일에 원본|보존url=은 |url=을 필요로 함 (도움말)에서 보존된 문서.|확인날짜=는 |url=을 필요로 함 (도움말)
Shirakihara Y, Evans PR (December 1988). “Crystal structure of the complex of phosphofructokinase from Escherichia coli with its reaction products”. 《J. Mol. Biol.》 204 (4): 973–94. doi:10.1016/0022-2836(88)90056-3. PMID2975709.
Banaszak K, Mechin I, Obmolova G, Oldham M, Chang SH, Ruiz T, Radermacher M, Kopperschläger G, Rypniewski W (March 2011). “The crystal structures of eukaryotic phosphofructokinases from baker's yeast and rabbit skeletal muscle”. 《J Mol Biol》 407 (7): 284–97. doi:10.1016/j.jmb.2011.01.019. PMID21241708.
Peskov K, Goryanin I, Demin O (August 2008). “Kinetic model of phosphofructokinase-1 from Escherichia coli”. 《J Bioinform Comput Biol》 6 (4): 843–67. doi:10.1142/S0219720008003643. PMID18763746.
Hellinga HW, Evans PR (1987). “Mutations in the active site of Escherichia coli phosphofructokinase”. 《Nature》 327 (6121): 437–9. doi:10.1038/327437a0. PMID2953977.
Papagianni M, Avramidis N (May 2012). “Engineering the central pathways in Lactococcus lactis: functional expression of the phosphofructokinase (pfk) and alternative oxidase (aox1) genes from Aspergillus niger in Lactococcus lactis facilitates improved carbon conversion rates under oxidizing conditions”. 《Enzyme and Microbial Technology》 51 (113): 125–30. doi:10.1016/j.enzmictec.2012.04.007. PMID22759530.
Coelho WS, Sola-Penna M (Jan 2013). “Serotonin regulates 6-phosphofructo-1-kinase activity in a PLC-PKC-CaMK II- and Janus kinase-dependent signaling pathway”. 《Mol. Cell. Biochem.》 372 (1–2): 211–20. doi:10.1007/s11010-012-1462-0. PMID23010892.
Nakajima H, Raben N, Hamaguchi T, Yamasaki T (March 2002). “Phosphofructokinase deficiency; past, present and future”. 《Curr. Mol. Med.》 2 (2): 197–212. doi:10.2174/1566524024605734. PMID11949936.
Bruser A, KirchbergerJ, Schoneberg T (Oct 2012). “Altered allosteric regulation of muscle 6-phosphofructokinase causes Tarui disease”. 《Biochem Biophys Res Commun》 427 (1): 133–7. doi:10.1016/j.bbrc.2012.09.024. PMID22995305.
Brüser A, Kirchberger J, Schöneberg T (October 2012). “Altered allosteric regulation of muscle 6-phosphofructokinase causes Tarui disease”. 《Biochem. Biophys. Res. Commun.》 427 (1): 133–7. doi:10.1016/j.bbrc.2012.09.024. PMID22995305.
Gomez LS, Zancan P, Marcondes MC, Ramos-Santos L, Meyer-Fernandes JR, Sola-Penna M, Da Silva D (Feb 2013). “Resveratrol decreases breast cancer cell viability and glucose metabolism by inhibiting 6-phosphofructo-1-kinase”. 《Biochimie》 95 (6): 1336–43. doi:10.1016/j.biochi.2013.02.013. PMID23454376.
Vaz CV, Alves MG, Marques R, Moreira PI, Oliveira PF, Maia CJ, Socorro S (Feb 2013). “Androgen-responsive and nonresponsive prostate cancer cells present a distinct glycolytic metabolism profile”. 《Int J Biochem Cell Biol》 44 (11): 2077–84. doi:10.1016/j.biocel.2012.08.013. PMID22964025.